KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.

KKR has made an investment in Henry Schein Inc, a Melville, New York-based provider of healthcare solutions to office-based dental and medical practitioners. Stanley Bergman serves as CEO of Henry ...

KKR & Co. has taken a 12% strategic stake in Henry Schein Inc and will work with the company to improve operations at the ...

In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on Cardinal Health (CAH – Research Report), with a ...

Some readers see legalization as a matter of personal liberty, others see tax revenue. Still others see more impaired drivers on the road and kids getting easier access to weed.

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Stocks to Buy or Sell. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against ...